Lunglife Ai, Inc

Lunglife AI Inc specialises in developing artificial intelligence solutions designed for the early detection and precision management of lung cancer. The primary aim of this US-based company is to significantly improve clinical outcomes and facilitate more timely intervention for patients affected by lung disease. Operating in the medical technology sector, Lunglife AI Inc specifically focuses on leveraging advanced AI algorithms to analyse medical imaging data, such as CT scans. Its work aims to enable earlier and more accurate diagnoses of lung conditions, ultimately improving patient prognoses. Track the share price of LLAI.L by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.